Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Jan Molenaar

Principal Investigator
Jan Molenaar
Prof. dr. Jan Molenaar leads a research group in the Princess Máxima Center, which focuses on precision medicine in pediatric cancer.
Phone +31 6 18051678
  • Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell

    • feb. 2021
    • Kildisiute, G., et al
    • Science advances
  • Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses

    • jan. 2021
    • Schubert, N., et al
    • European Journal of Cancer
  • Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours

    • aug. 2019
    • Jones, D., et al
    • Nature reviews. Cancer
  • From class waivers to precision medicine in paediatric oncology

    • jul. 2017
    • Pearson, A., et al
    • The Lancet Oncology
  • Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

    • aug. 2015
    • Eleveld, T., et al
    • Nature Genetics
View all publications